Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  1,409 results for ""Adjuvants, Immunologic""

Your Filters

Subject : cancer vaccines
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Spleen-Targeted mRNA Vaccine Doped with Manganese Adjuvant for Robust Anticancer Immunity In Vivo .

  • Authors : Luo Z; State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China.; Key Laboratory of Organ Regeneration and Reconstruction, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China.

Subjects: Manganese*/Manganese*/Manganese*/chemistry ; Manganese*/Manganese*/Manganese*/pharmacology ; Spleen*/Spleen*/Spleen*/immunology

  • Source: ACS nano [ACS Nano] 2024 Nov 05; Vol. 18 (44), pp. 30701-30715. Date of Electronic Publication: 2024 Oct 28.Publisher: American Chemical Society Country of Publication: United States NLM ID: 101313589 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Recent advances in mRNA-based cancer vaccines encoding immunostimulants and their delivery strategies.

  • Authors : Eslami SM; Department of Pharmaceutical Sciences, School of Pharmacy, University of Connecticut, Storrs, CT, USA. Electronic address: .; Lu X

Subjects: Cancer Vaccines*/Cancer Vaccines*/Cancer Vaccines*/administration & dosage ; Cancer Vaccines*/Cancer Vaccines*/Cancer Vaccines*/immunology ; Neoplasms*/Neoplasms*/Neoplasms*/therapy

  • Source: Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2024 Dec; Vol. 376, pp. 413-428. Date of Electronic Publication: 2024 Oct 24.Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 8607908 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

2D Differential Metallic Immunopotentiators Drive High Diversity and Capability of Antigen-specific Immunity Against Tumor.

  • Authors : Ren H; Materdicine Lab, School of Life Sciences, Shanghai University, Shanghai, 200444, China.; School of medicine, Shanghai University, Shanghai, 200444, China.

Subjects: Adjuvants, Immunologic* ; Cancer Vaccines*/Cancer Vaccines*/Cancer Vaccines*/immunology; Animals

  • Source: Advanced science (Weinheim, Baden-Wurttemberg, Germany) [Adv Sci (Weinh)] 2024 Oct; Vol. 11 (40), pp. e2405729. Date of Electronic Publication: 2024 Sep 03.Publisher: WILEY-VCH Country of Publication: Germany NLM ID: 101664569 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2198-3844

Record details

Read More Add to Saved list
×
Academic Journal

Dual Adjuvant-Loaded Peptide Antigen Self-Assembly Potentiates Dendritic Cell-Mediated Tumor Immunotherapy.

  • Authors : Kim J; Department of Bioengineering, Institute for Bioengineering and Biopharmaceutical Research, Hanyang University, Seoul, 04763, Republic of Korea.; Kang S

Subjects: Dendritic Cells*/Dendritic Cells*/Dendritic Cells*/immunology ; Immunotherapy*/Immunotherapy*/Immunotherapy*/methods ; Adjuvants, Immunologic*/Adjuvants, Immunologic*/Adjuvants, Immunologic*/administration & dosage

  • Source: Advanced science (Weinheim, Baden-Wurttemberg, Germany) [Adv Sci (Weinh)] 2024 Sep; Vol. 11 (36), pp. e2403663. Date of Electronic Publication: 2024 Jul 29.Publisher: WILEY-VCH Country of Publication: Germany NLM ID: 101664569 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2198-3844

Record details

Read More Add to Saved list
×
Academic Journal

A laponite-based immunologically active gel delivery system for long-acting tumor vaccine.

  • Authors : Zhang J; Tongji School of Pharmacy, Huazhong University of Science and Technology, Wuhan 430030, China.; Fu C

Subjects: Cancer Vaccines*/Cancer Vaccines*/Cancer Vaccines*/administration & dosage ; Cancer Vaccines*/Cancer Vaccines*/Cancer Vaccines*/immunology ; Silicates*/Silicates*/Silicates*/chemistry

  • Source: Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2024 Sep; Vol. 373, pp. 201-215. Date of Electronic Publication: 2024 Jul 17.Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 8607908 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Programming of in Situ Tumor Vaccines via Supramolecular Nanodrug/Hydrogel Composite and Deformable Nanoadjuvant for Cancer Immunotherapy.

  • Authors : Shao S; School of Biomedical Sciences and Engineering, South China University of Technology, Guangzhou International Campus, Guangzhou, Guangdong 511442, People's Republic of China.; Cao Z

Subjects: Cancer Vaccines*/Cancer Vaccines*/Cancer Vaccines*/chemistry ; Cancer Vaccines*/Cancer Vaccines*/Cancer Vaccines*/administration & dosage ; Cancer Vaccines*/Cancer Vaccines*/Cancer Vaccines*/immunology

  • Source: Nano letters [Nano Lett] 2024 Jul 24; Vol. 24 (29), pp. 9017-9026. Date of Electronic Publication: 2024 Jul 15.Publisher: American Chemical Society Country of Publication: United States NLM ID: 101088070 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Revolutionizing adjuvant development: harnessing AI for next-generation cancer vaccines.

  • Authors : Zhang WY; Dr. Neher's Biophysics Laboratory for Innovative Drug Discovery, State Key Laboratory of Quality Research in Chinese Medicine, Macau Institute for Applied Research in Medicine and Health, Macau University of Science and Technology, Macao, Macao SAR, China.; Zheng XL

Subjects: Cancer Vaccines*/Cancer Vaccines*/Cancer Vaccines*/immunology ; Cancer Vaccines*/Cancer Vaccines*/Cancer Vaccines*/therapeutic use ; Artificial Intelligence*

  • Source: Frontiers in immunology [Front Immunol] 2024 Aug 14; Vol. 15, pp. 1438030. Date of Electronic Publication: 2024 Aug 14 (Print Publication: 2024).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Orchestrated Codelivery of Peptide Antigen and Adjuvant to Antigen-Presenting Cells by Using an Engineered Chimeric Peptide Enhances Antitumor T-Cell Immunity.

  • Authors : Pan H; Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, Department of Laboratory Medicine, School of Public Health, Xiamen University, Xiamen, China.; National Institute of Diagnostics and Vaccine Development in Infectious Diseases, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Collaborative Innovation Center of Biologic Products, National Innovation Platform for Industry-Education Integration in Vaccine Research, NMPA Key Laboratory for Research and Evaluation of Infectious Disease Diagnostic Technology, The Research Unit of Frontier Technology of Structural Vaccinology of Chinese Academy of Medical Sciences, Xiamen University, Xiamen, China.

Subjects: Cancer Vaccines*/Cancer Vaccines*/Cancer Vaccines*/immunology ; Cancer Vaccines*/Cancer Vaccines*/Cancer Vaccines*/administration & dosage ; Antigen-Presenting Cells*/Antigen-Presenting Cells*/Antigen-Presenting Cells*/immunology

  • Source: Cancer immunology research [Cancer Immunol Res] 2024 Jul 02; Vol. 12 (7), pp. 905-920.Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101614637 Publication Model: Print Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Novel mRNA adjuvant ImmunER enhances prostate cancer tumor-associated antigen mRNA therapy via augmenting T cell activity.

  • Authors : Xu Z; Department of Urology, Pelvic Floor Disorders Center, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, Guangdong, China.; Xiao ZX

Subjects: Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/immunology ; Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/therapy ; Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/pathology

  • Source: Oncoimmunology [Oncoimmunology] 2024 Jun 27; Vol. 13 (1), pp. 2373526. Date of Electronic Publication: 2024 Jun 27 (Print Publication: 2024).Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Design, Synthesis, and Bioactivity Evaluation of a TF-Based Cancer Vaccine Candidate Using Lipid A Mimetics As a Built-In Adjuvant.

  • Authors : Gao L; Joint Laboratory for Translational Cancer Research of Chinese Medicine of the Ministry of Education of the People's Republic of China, International Institute for Translational Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.; Li G

Subjects: Lipid A*/Lipid A*/Lipid A*/analogs & derivatives ; Lipid A*/Lipid A*/Lipid A*/chemistry ; Lipid A*/Lipid A*/Lipid A*/pharmacology

  • Source: Journal of medicinal chemistry [J Med Chem] 2024 Jun 27; Vol. 67 (12), pp. 9976-9990. Date of Electronic Publication: 2024 Jun 17.Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
  • 1-10 of  1,409 results for ""Adjuvants, Immunologic""